Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2700

1.

Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.

Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.

Clin Ther. 2007 Nov;29(11):2319-32.

PMID:
18158074
[PubMed - indexed for MEDLINE]
2.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
[PubMed - indexed for MEDLINE]
3.

[Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].

Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.

Encephale. 2009 Dec;35(6):595-604. doi: 10.1016/j.encep.2009.10.011. Epub . French.

PMID:
20004291
[PubMed - indexed for MEDLINE]
4.

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.

Moore N, Verdoux H, Fantino B.

Int Clin Psychopharmacol. 2005 May;20(3):131-7.

PMID:
15812262
[PubMed - indexed for MEDLINE]
5.

Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.

Clin Drug Investig. 2007;27(7):481-92.

PMID:
17563128
[PubMed - indexed for MEDLINE]
6.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
[PubMed - indexed for MEDLINE]
7.

[Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram, in patients with major depressive disorder--the navigade switch study].

Schmitt L, Arbus C, Tonnoir B.

Encephale. 2006 Mar-Apr;32(2 Pt 1):270-7. French.

PMID:
16910629
[PubMed - indexed for MEDLINE]
8.

Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.

Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.

Clin Ther. 2009 Jun;31 Pt 1:1405-23. doi: 10.1016/j.clinthera.2009.07.006.

PMID:
19698901
[PubMed - indexed for MEDLINE]
9.

Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.

Wade AG, Fernández JL, François C, Hansen K, Danchenko N, Despiegel N.

Pharmacoeconomics. 2008;26(11):969-81.

PMID:
18850765
[PubMed - indexed for MEDLINE]
10.
11.

A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.

Colonna L, Andersen HF, Reines EH.

Curr Med Res Opin. 2005 Oct;21(10):1659-68.

PMID:
16238906
[PubMed - indexed for MEDLINE]
12.

Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.

Lepola U, Wade A, Andersen HF.

Int Clin Psychopharmacol. 2004 May;19(3):149-55. Erratum in: Int Clin Psychopharmacol. 2004 Jul;19(4):255.

PMID:
15107657
[PubMed - indexed for MEDLINE]
13.

A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.

Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.

Curr Med Res Opin. 2006 Jul;22(7):1331-41.

PMID:
16834832
[PubMed - indexed for MEDLINE]
14.

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.

Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.

Curr Med Res Opin. 2007 Jun;23(6):1303-18. Epub 2007 Apr 27.

PMID:
17559729
[PubMed - indexed for MEDLINE]
15.

[Escitalopram for treatment of major depressive disorder in adults].

Llorca PM, Brousse G, Schwan R.

Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. Review. French.

PMID:
16389716
[PubMed - indexed for MEDLINE]
16.

Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.

Ventura D, Armstrong EP, Skrepnek GH, Haim Erder M.

Curr Med Res Opin. 2007 Feb;23(2):245-50.

PMID:
17288677
[PubMed - indexed for MEDLINE]
17.

A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.

Bielski RJ, Ventura D, Chang CC.

J Clin Psychiatry. 2004 Sep;65(9):1190-6.

PMID:
15367045
[PubMed - indexed for MEDLINE]
18.

Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.

Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT.

Int Clin Psychopharmacol. 1999 Nov;14(6):329-37.

PMID:
10565799
[PubMed - indexed for MEDLINE]
19.

Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.

Kornstein SG, Li D, Mao Y, Larsson S, Andersen HF, Papakostas GI.

CNS Spectr. 2009 Jun;14(6):326-33.

PMID:
19668123
[PubMed - indexed for MEDLINE]
20.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.

J Clin Psychiatry. 2006 May;67(5):736-46.

PMID:
16841623
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk